{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(11)"],"submitter":["Wang X"],"pubmed_abstract":["<h4>Importance</h4>Supervised pelvic floor muscle training (PFMT) has been recommended as the first-line treatment for women with stress urinary incontinence (SUI), but more evidence on whether adjunctive methods would provide additional benefits is needed.<h4>Objective</h4>To compare the efficacy of PFMT with or without a home-based pressure-mediated biofeedback (BF) device.<h4>Design, setting, and participants</h4>This multicenter assessor-blinded randomized clinical trial was conducted in the obstetric clinics of 5 participating tertiary hospitals in China. Participants included eligible women with new-onset postpartum SUI who were enrolled from March 28, 2022, to October 13, 2023.<h4>Intervention</h4>All participants received 3 months of supervised PFMT and were randomized to either th"],"journal":["JAMA network open"],"pagination":["e2442925"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11539013"],"repository":["biostudies-literature"],"pubmed_title":["Pressure-Mediated Biofeedback With Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial."],"pmcid":["PMC11539013"],"pubmed_authors":["Qiu J","Fan G","Yang Y","Li D","Xu T","Mao X","Zhu X","Wang X","Wang Z","Wang J","Gao S","Sun Z"],"additional_accession":[]},"is_claimable":false,"name":"Pressure-Mediated Biofeedback With Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial.","description":"<h4>Importance</h4>Supervised pelvic floor muscle training (PFMT) has been recommended as the first-line treatment for women with stress urinary incontinence (SUI), but more evidence on whether adjunctive methods would provide additional benefits is needed.<h4>Objective</h4>To compare the efficacy of PFMT with or without a home-based pressure-mediated biofeedback (BF) device.<h4>Design, setting, and participants</h4>This multicenter assessor-blinded randomized clinical trial was conducted in the obstetric clinics of 5 participating tertiary hospitals in China. Participants included eligible women with new-onset postpartum SUI who were enrolled from March 28, 2022, to October 13, 2023.<h4>Intervention</h4>All participants received 3 months of supervised PFMT and were randomized to either th","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-06-03T01:02:08.287Z","creation":"2025-04-04T12:01:27.318Z"},"accession":"S-EPMC11539013","cross_references":{"pubmed":["39499517"],"doi":["10.1001/jamanetworkopen.2024.42925"]}}